Alphabet
Latest statistics and disclosures from Alphabet's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GTLB, ARM, RVMD, FRSH, CRWD, and represent 69.62% of Alphabet's stock portfolio.
- Added to shares of these 3 stocks: FRSH (+$44M), BHIL, WGS.
- Started 2 new stock positions in BHIL, WGS.
- Reduced shares in these 4 stocks: SNOW (-$48M), RVMD (-$48M), ILMN (-$5.6M), Star Peak Corp II.
- Sold out of its positions in Star Peak Corp II, ILMN.
- Alphabet was a net seller of stock by $-55M.
- Alphabet has $1.8B in assets under management (AUM), dropping by -6.70%.
- Central Index Key (CIK): 0001652044
Tip: Access up to 7 years of quarterly data
Positions held by Alphabet consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Alphabet
Alphabet holds 42 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Gitlab Class A Com (GTLB) | 27.3 | $503M | 9.8M | 51.54 |
|
|
| Arm Holdings Sponsored Ads (ARM) | 15.2 | $280M | 2.0M | 143.01 |
|
|
| Revolution Medicines (RVMD) | 10.5 | $193M | -19% | 4.3M | 45.35 |
|
| Freshworks Class A Com (FRSH) | 10.1 | $186M | +31% | 16M | 11.48 |
|
| Crowdstrike Hldgs Cl A (CRWD) | 6.5 | $120M | 428k | 280.47 |
|
|
| Uipath Cl A (PATH) | 4.9 | $90M | 7.0M | 12.80 |
|
|
| Tempus Ai Cl A (TEM) | 4.8 | $88M | 1.6M | 56.60 |
|
|
| Planet Labs Pbc Com Cl A (PL) | 3.9 | $71M | 32M | 2.23 |
|
|
| Dex (DXCM) | 3.8 | $70M | 1.0M | 67.04 |
|
|
| Verve Therapeutics (VERV) | 3.2 | $60M | 12M | 4.84 |
|
|
| Prime Medicine (PRME) | 3.2 | $58M | 15M | 3.87 |
|
|
| Snowflake Cl A (SNOW) | 0.7 | $13M | -78% | 115k | 114.86 |
|
| Sana Biotechnology (SANA) | 0.6 | $12M | 2.8M | 4.16 |
|
|
| Relay Therapeutics (RLAY) | 0.6 | $11M | 1.6M | 7.08 |
|
|
| Vera Therapeutics Cl A (VERA) | 0.6 | $11M | 241k | 44.20 |
|
|
| Oscar Health Cl A (OSCR) | 0.6 | $10M | 482k | 21.21 |
|
|
| Lyell Immunopharma (LYEL) | 0.4 | $8.1M | 5.9M | 1.38 |
|
|
| Beam Therapeutics (BEAM) | 0.4 | $7.9M | 322k | 24.50 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.4 | $7.8M | 1.5M | 5.30 |
|
|
| Dianthus Therapeutics (DNTH) | 0.3 | $5.7M | 209k | 27.38 |
|
|
| Tscan Therapeutics (TCRX) | 0.3 | $5.4M | 1.1M | 4.98 |
|
|
| Desktop Metal Com Cl A (DM) | 0.3 | $5.2M | 1.1M | 4.67 |
|
|
| Foghorn Therapeutics (FHTX) | 0.3 | $4.7M | 501k | 9.31 |
|
|
| Benson Hill Com New (BHIL) | 0.2 | $3.2M | NEW | 439k | 7.20 |
|
| Autolus Therapeutics Spon Adr (AUTL) | 0.1 | $2.5M | 698k | 3.63 |
|
|
| Barinthus Biotherapeutics Pl Ads (BRNS) | 0.1 | $1.8M | 1.5M | 1.19 |
|
|
| Tenaya Therapeutics (TNYA) | 0.1 | $1.8M | 916k | 1.93 |
|
|
| Fractyl Health (GUTS) | 0.1 | $1.7M | 663k | 2.53 |
|
|
| EXACT Sciences Corporation (EXAS) | 0.1 | $1.6M | 23k | 68.12 |
|
|
| Kronos Bio (KRON) | 0.1 | $1.4M | 1.4M | 1.00 |
|
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $1.3M | 641k | 2.01 |
|
|
| Spero Therapeutics (SPRO) | 0.1 | $1.2M | 890k | 1.34 |
|
|
| Rapt Therapeutics (RAPT) | 0.1 | $1.1M | 540k | 2.01 |
|
|
| Hyperfine Com Cl A (HYPR) | 0.1 | $971k | 899k | 1.08 |
|
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.1 | $969k | 449k | 2.16 |
|
|
| Genedx Holdings Corp (WGS) | 0.1 | $964k | NEW | 23k | 42.44 |
|
| Alector (ALEC) | 0.0 | $820k | 176k | 4.66 |
|
|
| Cortexyme (QNCX) | 0.0 | $148k | 189k | 0.78 |
|
|
| Repligen Corporation (RGEN) | 0.0 | $57k | 383.00 | 148.82 |
|
|
| Fulcrum Therapeutics (FULC) | 0.0 | $51k | 14k | 3.57 |
|
|
| Invitae (NVTAQ) | 0.0 | $0 | 236k | 0.00 |
|
|
| Cue Health (HLTHQ) | 0.0 | $0 | 27k | 0.00 |
|
Past Filings by Alphabet
SEC 13F filings are viewable for Alphabet going back to 2022
- Alphabet 2024 Q3 filed Nov. 8, 2024
- Alphabet 2024 Q2 filed Aug. 2, 2024
- Alphabet 2024 Q1 filed May 3, 2024
- Alphabet 2023 Q4 filed Feb. 9, 2024
- Alphabet 2023 Q3 filed Nov. 13, 2023
- Alphabet 2023 Q2 filed Aug. 4, 2023
- Alphabet 2023 Q1 filed May 11, 2023
- Alphabet 2022 Q4 filed Feb. 14, 2023
- Alphabet 2022 Q3 filed Nov. 15, 2022
- Alphabet 2013 Q4 filed Nov. 15, 2022
- Alphabet 2014 Q1 filed Nov. 15, 2022
- Alphabet 2014 Q2 filed Nov. 15, 2022
- Alphabet 2014 Q3 filed Nov. 15, 2022
- Alphabet 2014 Q4 filed Nov. 15, 2022
- Alphabet 2015 Q1 filed Nov. 15, 2022
- Alphabet 2015 Q2 filed Nov. 15, 2022